Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 229 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2786 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
OVIMA 21 | 30MCG 150MCG | TABLET | Resolved | 2023-04-27 | 2023-05-06 | 190868 |
OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2018-04-04 | 2018-05-03 | 44969 |
OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2019-06-05 | 2019-09-23 | 85622 |
OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2021-09-24 | 2021-11-15 | 146163 |
OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2022-01-07 | 2022-02-07 | 152329 |
OVIMA 28 | 30MCG 150MCG | TABLET | Resolved | 2023-03-02 | 2023-03-23 | 185933 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3.0G 0.375G | POWDER FOR SOLUTION | Actual shortage | 2017-03-11 | 2018-09-12 | 577 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.0G 0.5G | POWDER FOR SOLUTION | Actual shortage | 2017-03-11 | 2017-10-05 | 580 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | Actual shortage | 2017-03-11 | 2018-09-12 | 583 |
TIGECYCLINE | 50MG | POWDER FOR SOLUTION | Resolved | 2018-01-17 | 2018-08-22 | 36356 |
APO-TIZANIDINE | 4MG | TABLET | Resolved | 2019-04-29 | 2019-05-27 | 82759 |
APO-TRAMADOL | 50MG | TABLET | Resolved | 2018-01-09 | 2018-02-01 | 35364 |
APO-TRAMADOL | 50MG | TABLET | Resolved | 2019-03-06 | 2019-03-21 | 77928 |
TRI-CIRA 21 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | TABLET | Resolved | 2022-12-02 | 2023-03-16 | 176945 |
TRI-CIRA 21 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | TABLET | Resolved | 2023-04-06 | 2023-08-12 | 188979 |
TRI-CIRA 21 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | TABLET | Resolved | 2024-01-05 | 2024-02-02 | 215236 |
TRI-CIRA 28 | 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG | TABLET | Resolved | 2023-03-23 | 2023-08-12 | 187715 |
TRI-CIRA LO 21 | 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG | TABLET | Resolved | 2022-02-22 | 2022-03-07 | 155371 |
TRI-CIRA LO 21 | 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG | TABLET | Resolved | 2022-10-28 | 2023-04-14 | 172942 |
TRI-CIRA LO 21 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2018-01-18 | 2018-02-23 | 36429 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
APO-CAPTO TAB 6.25MG | 6.25MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60339 |
APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |